![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1316353 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ELOVL3 mRNA | CTD | PMID:36331819 | (R)-noradrenaline | multiple interactions | ISO | RGD:1316353 | 6480464 | [Dexamethasone co-treated with Norepinephrine] results in increased expression of ELOVL3 mRNA more ... | CTD | PMID:17726147 | (R)-noradrenaline | increases expression | ISO | RGD:1316353 | 6480464 | Norepinephrine results in increased expression of ELOVL3 mRNA | CTD | PMID:17726147 | 17beta-estradiol | decreases expression | ISO | RGD:1316353 | 6480464 | Estradiol results in decreased expression of ELOVL3 mRNA | CTD | PMID:19484750 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:1316352 | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:1316353 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1316352 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELOVL3 mRNA | CTD | PMID:21998131 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ELOVL3 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1316353 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELOVL3 mRNA | CTD | PMID:28213091 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1316353 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ELOVL3 mRNA | CTD | PMID:26377647 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1316352 | 6480464 | Lactic Acid results in decreased expression of ELOVL3 mRNA | CTD | PMID:30851411 | 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | RGD:1316353 | 6480464 | [tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA | CTD | PMID:34323617 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1316353 | 6480464 | [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA more ... | CTD | PMID:34323617 | 3-methylcholanthrene | increases expression | ISO | RGD:1316353 | 6480464 | Methylcholanthrene results in increased expression of ELOVL3 mRNA | CTD | PMID:25926378 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1316353 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of ELOVL3 mRNA | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1316353 | 6480464 | Fenretinide results in increased expression of ELOVL3 mRNA | CTD | PMID:28973697 | actinomycin D | multiple interactions | ISO | RGD:1316353 | 6480464 | Dactinomycin inhibits the reaction [Norepinephrine results in increased expression of ELOVL3 mRNA], Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] | CTD | PMID:17726147 | aristolochic acid A | increases expression | ISO | RGD:1316352 | 6480464 | aristolochic acid I results in increased expression of ELOVL3 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | ISO | RGD:1316353 | 6480464 | Benzo(a)pyrene results in decreased expression of ELOVL3 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | RGD:1316352 | 6480464 | Benzo(a)pyrene results in increased methylation of ELOVL3 exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1316352 | 6480464 | Benzo(a)pyrene affects the methylation of ELOVL3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1316352 | 6480464 | Benzo(a)pyrene results in increased expression of ELOVL3 mRNA | CTD | PMID:20106945, PMID:21632981 | beta-naphthoflavone | decreases expression | ISO | RGD:1316353 | 6480464 | beta-Naphthoflavone results in decreased expression of ELOVL3 mRNA | CTD | PMID:28973660 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1316353 | 6480464 | Diethylhexyl Phthalate results in increased expression of ELOVL3 mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1316353 | 6480464 | Diethylhexyl Phthalate results in decreased expression of ELOVL3 mRNA | CTD | PMID:19245819 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1316353 | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ELOVL3 mRNA] | CTD | PMID:19850644 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ELOVL3 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | RGD:1316352 | 6480464 | bisphenol A results in decreased methylation of ELOVL3 gene | CTD | PMID:31601247 | butanal | increases expression | ISO | RGD:1316352 | 6480464 | butyraldehyde results in increased expression of ELOVL3 mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | ISO | RGD:1316353 | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | RGD:1316352 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ELOVL3 gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | RGD:1316353 | 6480464 | [Dietary Fats co-treated with Choline deficiency] results in decreased expression of ELOVL3 mRNA, PANX1 gene mutant form promotes the reaction [[Dietary Fats co-treated with Choline deficiency] results in decreased expression of ELOVL3 mRNA] | CTD | PMID:29246445 | ciprofibrate | decreases expression | ISO | RGD:1316353 | 6480464 | ciprofibrate results in decreased expression of ELOVL3 mRNA | CTD | PMID:12771043 | cisplatin | increases expression | ISO | RGD:1316352 | 6480464 | Cisplatin results in increased expression of ELOVL3 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:1316352 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ELOVL3 mRNA | CTD | PMID:27392435 | clofibrate | multiple interactions | ISO | RGD:1316353 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA] | CTD | PMID:17585979 | clofibrate | increases expression | ISO | RGD:1316353 | 6480464 | Clofibrate results in increased expression of ELOVL3 mRNA | CTD | PMID:17585979, PMID:23811191 | cycloheximide | decreases expression | ISO | RGD:1316353 | 6480464 | Cycloheximide results in decreased expression of ELOVL3 mRNA | CTD | PMID:17726147 | cycloheximide | multiple interactions | ISO | RGD:1316353 | 6480464 | Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of ELOVL3 mRNA] | CTD | PMID:17726147 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of ELOVL3 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | RGD:1316353 | 6480464 | [Dexamethasone co-treated with Norepinephrine] results in increased expression of ELOVL3 mRNA more ... | CTD | PMID:17726147, PMID:34323617 | dibutyl phthalate | increases expression | ISO | RGD:1316353 | 6480464 | Dibutyl Phthalate results in increased expression of ELOVL3 mRNA | CTD | PMID:17361019, PMID:21266533 | dichloroacetic acid | decreases expression | ISO | RGD:1316353 | 6480464 | Dichloroacetic Acid results in decreased expression of ELOVL3 mRNA | CTD | PMID:28962523 | epoxiconazole | increases expression | ISO | RGD:1316353 | 6480464 | epoxiconazole results in increased expression of ELOVL3 mRNA | CTD | PMID:35436446 | ethanol | decreases expression | ISO | RGD:1316353 | 6480464 | Ethanol results in decreased expression of ELOVL3 mRNA | CTD | PMID:19167417 | furan | decreases expression | ISO | RGD:1316353 | 6480464 | furan results in decreased expression of ELOVL3 mRNA | CTD | PMID:24183702 | Geniposide | decreases expression | ISO | RGD:1316353 | 6480464 | geniposide results in decreased expression of ELOVL3 mRNA | CTD | PMID:34718029 | genistein | decreases expression | ISO | RGD:1316353 | 6480464 | Genistein results in decreased expression of ELOVL3 mRNA | CTD | PMID:24967385 | genistein | increases expression | ISO | RGD:1316352 | 6480464 | Genistein results in increased expression of ELOVL3 mRNA | CTD | PMID:20884965 | graphene oxide | decreases expression | ISO | RGD:1316353 | 6480464 | graphene oxide results in decreased expression of ELOVL3 mRNA | CTD | PMID:33227293 | indinavir | multiple interactions | ISO | RGD:1316353 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA | CTD | PMID:16931933 | lamivudine | multiple interactions | ISO | RGD:1316353 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA more ... | CTD | PMID:16931933 | linalool | decreases expression | ISO | RGD:1316352 | 6480464 | linalool results in decreased expression of ELOVL3 mRNA | CTD | PMID:24752549 | lipopolysaccharide | decreases expression | ISO | RGD:1316353 | 6480464 | Lipopolysaccharides results in decreased expression of ELOVL3 mRNA | CTD | PMID:27339419 | mercury dichloride | decreases response to substance | ISO | RGD:1316352 | 6480464 | ELOVL3 protein results in decreased susceptibility to Mercuric Chloride | CTD | PMID:24118919 | mercury dichloride | increases expression | ISO | RGD:1316352 | 6480464 | Mercuric Chloride results in increased expression of ELOVL3 mRNA | CTD | PMID:24118919 | methotrexate | affects expression | ISO | RGD:1316353 | 6480464 | Methotrexate affects the expression of ELOVL3 mRNA | CTD | PMID:18502557 | methylmercury chloride | increases expression | ISO | RGD:1316352 | 6480464 | methylmercuric chloride results in increased expression of ELOVL3 mRNA | CTD | PMID:24118919 | methylmercury chloride | decreases response to substance | ISO | RGD:1316352 | 6480464 | ELOVL3 protein results in decreased susceptibility to methylmercuric chloride | CTD | PMID:24118919 | N-nitrosodiethylamine | decreases expression | ISO | RGD:1316353 | 6480464 | Diethylnitrosamine results in decreased expression of ELOVL3 mRNA | CTD | PMID:12771043, PMID:24535843 | nickel atom | decreases expression | ISO | RGD:1316352 | 6480464 | Nickel results in decreased expression of ELOVL3 mRNA | CTD | PMID:24768652 | nickel sulfate | multiple interactions | ISO | RGD:1316353 | 6480464 | [nickel sulfate co-treated with Particulate Matter] results in decreased expression of ELOVL3 mRNA | CTD | PMID:23126276 | ozone | decreases expression | ISO | RGD:1316353 | 6480464 | Ozone results in decreased expression of ELOVL3 mRNA | CTD | PMID:16183385 | paracetamol | multiple interactions | ISO | RGD:1316353 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ELOVL3 mRNA more ... | CTD | PMID:17585979 more ... | paracetamol | decreases expression | ISO | RGD:1316353 | 6480464 | Acetaminophen results in decreased expression of ELOVL3 mRNA | CTD | PMID:29246445 | paracetamol | affects expression | ISO | RGD:1316353 | 6480464 | Acetaminophen affects the expression of ELOVL3 mRNA | CTD | PMID:17562736 | parathion | decreases expression | ISO | RGD:1316353 | 6480464 | Parathion results in decreased expression of ELOVL3 mRNA | CTD | PMID:34813904 | pentanal | increases expression | ISO | RGD:1316352 | 6480464 | pentanal results in increased expression of ELOVL3 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1316353 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ELOVL3 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELOVL3 mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | RGD:1316353 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ELOVL3 mRNA] | CTD | PMID:19482888 | phenobarbital | affects expression | ISO | RGD:1316353 | 6480464 | Phenobarbital affects the expression of ELOVL3 mRNA | CTD | PMID:23091169 | phenobarbital | decreases expression | ISO | RGD:1316353 | 6480464 | Phenobarbital results in decreased expression of ELOVL3 mRNA | CTD | PMID:19270015, PMID:19482888 | pirinixic acid | multiple interactions | ISO | RGD:1316352 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ELOVL3 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:1316353 | 6480464 | pirinixic acid results in increased expression of ELOVL3 mRNA | CTD | PMID:16357043 more ... | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1316353 | 6480464 | Pregnenolone Carbonitrile results in increased expression of ELOVL3 mRNA | CTD | PMID:28903501 | propanal | increases expression | ISO | RGD:1316352 | 6480464 | propionaldehyde results in increased expression of ELOVL3 mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | RGD:1316352 | 6480464 | Quercetin results in increased expression of ELOVL3 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | RGD:1316352 | 6480464 | Lactic Acid results in decreased expression of ELOVL3 mRNA | CTD | PMID:30851411 | resveratrol | increases expression | ISO | RGD:1316353 | 6480464 | resveratrol results in increased expression of ELOVL3 mRNA | CTD | PMID:25761413 | resveratrol | multiple interactions | ISO | RGD:1316353 | 6480464 | PRKAA1 gene mutant form inhibits the reaction [Resveratrol results in increased expression of ELOVL3 mRNA], Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ELOVL3 mRNA] | CTD | PMID:25761413, PMID:31298478 | saquinavir | multiple interactions | ISO | RGD:1316353 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA | CTD | PMID:16931933 | silicon dioxide | decreases expression | ISO | RGD:1316352 | 6480464 | Silicon Dioxide analog results in decreased expression of ELOVL3 mRNA | CTD | PMID:25895662 | tamoxifen | affects expression | ISO | RGD:1316353 | 6480464 | Tamoxifen affects the expression of ELOVL3 mRNA | CTD | PMID:20937368 | testosterone | increases expression | ISO | RGD:1316353 | 6480464 | Testosterone results in increased expression of ELOVL3 mRNA | CTD | PMID:20844152 | tetrachloroethene | decreases expression | ISO | RGD:1316353 | 6480464 | Tetrachloroethylene results in decreased expression of ELOVL3 mRNA | CTD | PMID:28973375 | tetrachloromethane | decreases expression | ISO | RGD:1316353 | 6480464 | Carbon Tetrachloride results in decreased expression of ELOVL3 mRNA | CTD | PMID:27339419 more ... | tetrachloromethane | multiple interactions | ISO | RGD:1316353 | 6480464 | PANX1 protein affects the reaction [Carbon Tetrachloride results in decreased expression of ELOVL3 mRNA] | CTD | PMID:29987408 | tetracycline | increases expression | ISO | RGD:1316353 | 6480464 | Tetracycline results in increased expression of ELOVL3 mRNA | CTD | PMID:16917069 | titanium dioxide | multiple interactions | ISO | RGD:1316353 | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ELOVL3 mRNA] | CTD | PMID:31298478 | titanium dioxide | decreases expression | ISO | RGD:1316353 | 6480464 | titanium dioxide results in decreased expression of ELOVL3 mRNA | CTD | PMID:31298478 | tributylstannane | decreases expression | ISO | RGD:1316353 | 6480464 | tributyltin results in decreased expression of ELOVL3 mRNA | CTD | PMID:31939706 | trichloroethene | decreases expression | ISO | RGD:1316353 | 6480464 | Trichloroethylene results in decreased expression of ELOVL3 mRNA | CTD | PMID:19448997, PMID:28973375 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ELOVL3 mRNA | CTD | PMID:33387578 | triphenyl phosphate | multiple interactions | ISO | RGD:1316353 | 6480464 | [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA | CTD | PMID:34323617 | urethane | increases expression | ISO | RGD:1316352 | 6480464 | Urethane results in increased expression of ELOVL3 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1316353 | 6480464 | Valproic Acid affects the expression of ELOVL3 mRNA | CTD | PMID:17292431, PMID:17963808 | valproic acid | increases expression | ISO | RGD:1316352 | 6480464 | Valproic Acid results in increased expression of ELOVL3 mRNA | CTD | PMID:23179753 more ... | zidovudine | multiple interactions | ISO | RGD:1316353 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ELOVL3 mRNA more ... | CTD | PMID:16931933 | |